“Hablemos de Alzheimer”: Words Mexican Americans use to talk about Alzheimer’s disease genetic testing. Implications for precision medicine education.

Effective Alzheimer’s disease (AD) diagnosis and therapy will require a tailored approach to each person’s unique AD manifestation, known as AD precision medicine (PM). PM‐associated comprehensive genetic testing is currently restricted to the research domain and not readily available to minoritized Hispanics/Latinos (H/L). Successful AD precision medicine programs benefitting everyone require culturally appropriate patient outreach/education materials. We investigated the words H/L use to talk about AD genetic testing.